Skip to content

Company information lookup

INVION LIMITED (IVX)

Clinical-stage pharmaceutical drug development

On this page you will find:

Delayed share price
Company announcements
Price history chart
Exchange Traded Options
ASX-Listed Emblem Company details
Closing prices
Dividends
Warrants & Structured Products

Delayed share price

Prices are delayed by 20 minutes unless stated otherwise in the Conditions. Retrieving any price indicates your acceptance of the Conditions.

Code Last % Chg Bid Offer Open High Low Vol
IVX 0.055 3.77% 0.052 0.056 0.053 0.055 0.052 286,190

INVION LIMITED details

Please note: ASX relies on third parties to provide the information contained in the company details table, and therefore is unable to assume any responsibility for the accuracy or timeliness of the information.

Issuer Code IVX
Securities
Official Listing Date 15 February, 2010
GICS Industry Group Pharmaceuticals & Biotechnology
Exempt Foreign? No
Internet Address http://www.inviongroup.com
Registered Office Address c/- McCullough Robertson Lawyers, Level 11, 66 Eagle Street, Brisbane, QLD, AUSTRALIA, 4000
Head Office Telephone +61 7 3295 0500
Head Office Fax +61 7 3295 0599
Share Registry LINK MARKET SERVICES LIMITED
LEVEL 15, 324 QUEEN STREET, BRISBANE, QLD, AUSTRALIA, 4000
Share Registry Telephone 1300 554 474
Directors / Senior Management
Dr Ralph Craven (Chairman)
Dr Greg Collier (Managing Director, CEO)
Dr Mitchell Glass (Executive Director)
Mr Warren Brown (Non Exec. Director)
Dr James Campbell (Non Exec. Director)
Mr Brett Heading (Non Exec. Director)
Company Secretary Ms Melanie Farris
Principal Activities Clinical-stage pharmaceutical drug development

INVION LIMITED announcements

How are company announcements published on www.asx.com.au?

Date Price
sens.
Headline Pages PDF
21/11/2014   Notice under Section 708A 1 PDF
21/11/2014   Appendix 3B 14 PDF
21/11/2014   Results of Annual General Meeting 1 PDF
21/11/2014   CEO presentation to AGM 24 PDF
21/11/2014   Chairman's Address to Shareholders 2 PDF
10/11/2014   Notice under Section 708A 1 PDF
10/11/2014   Appendix 3B 13 PDF
10/11/2014 asterix Funding Agreement with Australian Special Opportunity Fund 2 PDF
31/10/2014   Annual Report to shareholders 84 PDF
31/10/2014 asterix Appendix 4C - quarterly 5 PDF

> search for past company announcements

Viewing Market Announcements:
Users of Adobe Acrobat Reader version 6.0.0 may have difficulty accessing PDF announcements. Symptoms include slow downloads, blank documents, and small white boxes appearing in the PDF. We recommend you download the latest version of the free Adobe Acrobat Reader. To check which version you have, open Adobe Acrobat Reader, click on 'Help', then click 'About Adobe Reader 6.0'.

Closing prices

Closing prices are displayed for the last 5 days on which the security traded on ASX within the last 6 months.

Date Last % Change High Low Vol *
21 Nov 2014 0.055 3.77% 0.055 0.052 286,190
20 Nov 2014 0.053 -5.36% 0.056 0.053 572,370
19 Nov 2014 0.056 0% 0.056 0.056 146,893
18 Nov 2014 0.056 -1.75% 0.057 0.054 919,225
17 Nov 2014 0.057 -1.72% 0.059 0.056 650,700

* Volume of shares shown represents only those shares traded on ASX.

INVION LIMITED price history chart

* More charting options are available.

Dividends

How are dividends released on www.asx.com.au?

No dividends have been found for the security IVX. This is likely to be because a dividend has not been announced to the ASX by this company during the specified timeframe or a dividend has been announced but is not yet available on this website.

Exchange Traded Options

No Exchange Traded Options are available over the security IVX

Warrants & Structured Products

No warrants & Structured Products are available over the security IVX